Bionomics Ltd


Bionomics is a biopharmaceutical company dedicated to making better treatments for cancer, central nervous system disorders such as anxiety, depression and Alzheimer's disease. Bionomins are in a strong growth phase with their world-class portfolio of promising drug candidates from early to advanced stages of clinical development. This portfolio is fed by highly productive drug discovery platforms that includes MultiCore®, their proprietary chemistry capability.

Bionomics partner with large pharmaceutical companies to get their drugs through the later stages of development and into the market as rapidly as possible. This means they can focus their strengths in innovative drug discovery to extract as many "shots on goal" from their diverse pipeline in the quest to create the world's new blockbuster drugs.